Milisauskas V K, Nakamura I
Department of Pathology, SUNY at Buffalo 14214.
Eur J Immunol. 1994 Feb;24(2):336-42. doi: 10.1002/eji.1830240210.
F1 hybrid resistance (HR) to parental bone marrow grafts is mediated by natural killer (NK) cells, and thought to be controlled by the non-class I hemopoietic histocompatibility (Hh) genes linked to the major histocompatibility complex (MHC). However, as in the in vitro NK cytotoxicity against hemopoietic targets, expression of certain class I MHC molecules does affect HR, although mechanisms underlying such an effect are not understood. In this study, we examine the relevance of the "self/non-self" property of class I molecules and the molecular domains responsible for this function. H-2b/Hh-1b lymphoma cells were transfected with class I H-2Dd or Ld gene, and its effect on the Hh-1 phenotype was examined by testing the transfectant's ability to competitively inhibit the in vivo rejection of parental H-2b/Hh-1b bone marrow grafts by irradiated F1 hybrid hosts. Multiple independent clones of transfectants show that the genomic or cDNA of the Dd gene, but not of Ld, renders the Hh-1b-positive cells incapable of inhibiting HR in F1 mice, although both genes belong to the same region of the same haplotype. The same effect could be observed not only in H-2b/d F1 mice for which Dd and Ld are self, but also in H-2b/k F1 mice for which both Dd and Ld are non-self. Thus, this function of the Dd molecule is an intrinsic property, not necessarily related to its self/non-self characteristic relative to the effector cells. Furthermore, given the nature of the assay used in this study, the results favor a "target interference" model as the underlying mechanism of the Dd effect. To locate the relevant domain(s) of the Dd molecule, mutant Ddm1 gene was tested and found to have the same effect as the non-mutant Dd. Ddm1 is a hybrid molecule between Dd and Ld, sharing with Dd only the alpha 1 domain and a portion of the alpha 2 domain. The two N-terminal domains of Ddm1 differ from those of Dd by three amino acid substitutions, two of which affect the molecules' peptide-binding properties.
F1杂种对亲代骨髓移植的抗性(HR)由自然杀伤(NK)细胞介导,并且被认为受与主要组织相容性复合体(MHC)连锁的非I类造血组织相容性(Hh)基因控制。然而,如同体外NK细胞对造血靶标的细胞毒性一样,某些I类MHC分子的表达确实会影响HR,尽管这种影响的潜在机制尚不清楚。在本研究中,我们研究了I类分子“自身/非自身”特性的相关性以及负责此功能的分子结构域。用I类H-2Dd或Ld基因转染H-2b/Hh-1b淋巴瘤细胞,并通过测试转染细胞竞争性抑制经照射的F1杂种宿主对亲代H-2b/Hh-1b骨髓移植的体内排斥反应的能力,来检测其对Hh-1表型的影响。多个独立的转染细胞克隆表明,Dd基因的基因组或cDNA,而非Ld基因的,使Hh-1b阳性细胞无法抑制F1小鼠中的HR,尽管这两个基因属于同一单倍型的同一区域。不仅在Dd和Ld为自身分子的H-2b/d F1小鼠中,而且在Dd和Ld均为非自身分子的H-2b/k F1小鼠中,都能观察到相同的效应。因此,Dd分子的这种功能是一种内在特性,不一定与其相对于效应细胞的自身/非自身特征相关。此外,鉴于本研究所用检测方法的性质,结果支持“靶标干扰”模型作为Dd效应的潜在机制。为了定位Dd分子的相关结构域,对突变的Ddm1基因进行了测试,发现其与非突变的Dd具有相同的效应。Ddm1是Dd和Ld之间的杂种分子,仅与Dd共享α1结构域和部分α2结构域。Ddm1的两个N端结构域与Dd的不同,有三个氨基酸替换,其中两个影响分子的肽结合特性。